Abstract
Aim. To assess the quality of arterial hypertension (HT) pharmacotherapy within the outpatient register RECVASA, emphasizing whether the choice of antihypertensive drugs (AHD) is in line with current clinical guidelines. Material and methods. Patients with HT without ischemic heart disease, chronic heart failure and atrial fibrillation (n=741) were selected from all patients (n=3690) included into the register. Among concomitant diseases were revealed the following: bronchial asthma and/or chronic obstructive pulmonary disease (COPD) – in 42 (5.7%) patients; obesity – in 93 patients, impaired glucose tolerance – in 9 patients, and diabetes mellitus – 84 patients. Prescription of AHD, their number and class were recorded at every next visit to doctor. Accuracy of AHD choice, compliance with current clinical guidelines, and other considerations were assessed through the example of beta-blockers (BBs). Results. AHD were prescribed to 641 patients, and in 13.5% of patients did not receive any AHD. 49.7% of patients received ACE inhibitors, 38.5% – diuretics, 32.5% – BBs. BBs were prescribed to the third part of patients with diabetes and obesity. Furthermore a quarter patients with COPD and the third part of patients with bronchial asthma received BBs. BBs in combination with thiazide diuretics were prescribed to 12 (41.4%) patients with diabetes mellitus and to 13 (40.6%) patients with obesity. Conclusion. Doctors do not always make AHD choice according to current clinical guidelines. Compliance of AHD choice with current clinical guidelines should be an element of treatment quality assessment.
Highlights
antihypertensive drugs (AHD) were prescribed to 641 patients, and in 13.5% of patients did not receive any AHD. 49.7% of patients received ACE inhibitors, 38.5% – diuretics, 32.5% – BBs
Регистр РЕКВАЗА является амбулаторно-поликлиническим регистром кардиологических больных, который проводится в г
8. Boytsov SA, Jakushin SS, Martsevich SYu et al Outpatient polyclinic case of cardiovascular diseases in the Ryazan region (RECVASA): key challenges, the experience of creating and first results
Summary
Регистр РЕКВАЗА является амбулаторно-поликлиническим регистром кардиологических больных, который проводится в г. Для решения поставленной цели исследования из 3690 больных, включенных в регистр РЕКВАЗА, были отобраны амбулаторные карты 741 пациента с АГ без сочетания с другими ССЗ (ИБС, ХСН и ФП), что позволило исключить влияние препаратов, применяемых для лечения других видов сердечно-сосудистой патологии на процесс контроля АД. 1 приведена общая характеристика вошедшей в исследование группы больных с АГ без сочетания с другими ССЗ. 1 представлены данные о количестве назначенных АГП 641 больному с АГ без сочетания с другими ССЗ. 13,5% больным АГП вообще не были назначены, хотя только 4 (4%) больных из этой группы имели АГ 1 степени; 39% имели 2 степень АГ и 32% – 3 степень АГ (у 25% больных степень не указывалась). Частота наличия различных ограничений (противопоказаний) к назначению ББ больным АГ без сочетания с другими ССЗ
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
